Clinical Trial Update: MAGE of Anagliptin Compared With Sitagliptin With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial comparing MAGE of Anagliptin with Sitagliptin in type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Anagliptin (MAGE of Anagliptin) (anagliptin)
• Sitagliptin (sitagliptin)

Snippet

Sponsor: JW Pharmaceutical | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED